Prof. Dr. med. Thomas Brabletz

Lehrstuhl für Experimentelle Medizin mit dem Schwerpunkt Molekulare Pathogeneseforschung

Road to perdition: Zeb1-dependent and -independent ways to metastasis (2017) Brabletz S, Brabletz T, Stemmler M Journal article ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types (2016) Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, Herr R, et al. Journal article The Wnt Target Gene L1 in Colon Cancer Invasion and Metastasis (2016) Haase G, Gavert N, Brabletz T, Ben-Ze'Ev A Journal article ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer (2016) Strietz J, Stepputtis SS, Preca BT, Vannier C, Kim MM, Castro DJ, Au Q, et al. Journal article Inappropriate cadherin switching in the mouse epiblast compromises proper signaling between the epiblast and the extraembryonic ectoderm during gastrulation (2016) Basilicata MF, Frank M, Solter D, Brabletz T, Stemmler M Journal article Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression (2016) Shvab A, Haase G, Ben-Shmuel A, Gavert N, Brabletz T, Dedhar S, Ben-Ze'Ev A Journal article MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation (2016) Anderson S, Poudel KR, Roh-Johnson M, Brabletz T, Yu M, Borenstein-Auerbach N, Grady WN, et al. Journal article The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5 (2015) Sundararajan V, Gengenbacher N, Stemmler M, Kleemann J, Brabletz T, Brabletz S Journal article The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors (2015) Mock K, Preca BT, Brummer T, Brabletz S, Stemmler M, Brabletz T Journal article ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat (2015) Meidhof S, Brabletz S, Lehmann W, Preca BT, Mock K, Ruh M, Schueler J, et al. Journal article